Commercial products marketed as GLP-1 patches do not contain real GLP-1 medication and should not be considered safe or effective treatments
Altintas stressed that The findings should be viewed as hypothesis-generating rather than practice-changing. The study suggests that semaglutide does not appear to increase fracture risk and may potentially reduce it, but randomized prospective studies with bone mineral density, bone turnover markers, and fracture endpoints will be needed before concluding that semaglutide has true bone-protective properties, he told us
Biopharma PEG supplies polyethylene glycol (PEG) derivatives, monodisperse PEGs, custom PEG derivative synthesis and PEGylation services worldwide, from R&D through GMP commercial quantities, for preclinical, clinical trials, and commercial products for pharma, biotech, medical devices, and diagnostics
Overall, the effects of these compounds on fat metabolism, body mass index, lean mass, and insulin sensitivity might show changes in body weight on long-term treatment, yet they are less likely to offer the same results as GLP-1 patches
If youre taking the maximum dose of metformin and your blood sugar or A1C levels arent improving, adding a GLP-1 could be the next step